Abstract

Establishing symptom-based predictors of electroconvulsive therapy (ECT) outcome seems promising, however, findings concerning the predictive value of distinct depressive symptoms or subtypes are limited; previous factor-analytic approaches based on the Montgomery–Åsberg Depression Rating Scale (MADRS) remained inconclusive, as proposed factors varied across samples. In this naturalistic study, we refrained from these previous factor-analytic approaches and examined the predictive value of MADRS single items and their change during the course of ECT concerning ECT outcome. We used logistic and linear regression models to analyze MADRS data routinely assessed at three time points in 96 depressed psychiatric inpatients over the course of ECT. Mean age was 53 years (SD 14.79), gender ratio was 58:38 (F:M), baseline MADRS score was M = 30.20 (SD 5.42). MADRS single items were strong predictors of ECT response, remission and overall symptom reduction, especially items 1 (apparent sadness), 2 (reported sadness) and 8 (inability to feel), assessing affective symptoms. Strongest effects were found for regression models including item 2 (reported sadness) with up to 80% correct prediction of ECT outcome. ROC analyses were performed to estimate the optimal cut-point for treatment response. MADRS single items during the course of ECT might pose simple, reliable, time- and cost-effective predictors of ECT outcome. More severe affective symptoms of depression at baseline and a stronger reduction of these affective symptoms during the course of ECT seem to be positively associated with ECT outcome. Precise cut-off values for clinical use were proposed. Generally, these findings underline the benefits of a symptom-based approach in depression research and treatment in addition to depression sum-scores and generalized diagnoses.

Highlights

  • Electroconvulsive therapy (ECT) is one of the most effective treatment options for depressive disorders, recommended especially for the treatment of severe and treatment-resistant depression [1, 2]

  • Participants were psychiatric inpatients diagnosed with a current depressive episode in accordance with DSM-5 who were treated with ECT at Charité—Universitätsmedizin Berlin

  • Area under the curve was 0.65, p = 0.013, optimal cut point by Youden-index was item 2 = 5. In this retrospective naturalistic study, we examined 96 psychiatric inpatients diagnosed with a depressive episode who were treated with ECT at Charité—Universitätsmedizin Berlin

Read more

Summary

Introduction

Electroconvulsive therapy (ECT) is one of the most effective treatment options for depressive disorders, recommended especially for the treatment of severe and treatment-resistant depression [1, 2]. Even though response rates are generally high (60–80%) [3], a relevant percentage of patients shows no or only partial response [4]. Response time and course of action during ECT vary substantially [4]. Different mechanisms of actions are discussed in the literature (e.g. neurobiological factors such as enhancement of serotonergic neurotransmission and activation of the mesocorticolimbic dopamine system) [3]. The precise antidepressant mechanisms of ECT remain unclear, potentially further impeding treatment prediction [5]. Electroconvulsive therapy can be regarded as a relatively costly, intensive

Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.